A more tubulocentric view of diabetic kidney disease
Top Cited Papers
Open Access
- 24 August 2017
- journal article
- review article
- Published by Springer Science and Business Media LLC in Journal of Nephrology
- Vol. 30 (6), 701-717
- https://doi.org/10.1007/s40620-017-0423-9
Abstract
Diabetic nephropathy (DN) is a common complication of Diabetes Mellitus (DM) Types 1 and 2, and prevention of end stage renal disease (ESRD) remains a major challenge. Despite its high prevalence, the pathogenesis of DN is still controversial. Initial glomerular disease manifested by hyperfiltration and loss of glomerular size and charge permselectivity may initiate a cascade of injuries, including tubulo-interstitial disease. Clinically, ‘microalbuminuria’ is still accepted as an early biomarker of glomerular damage, despite mounting evidence that its predictive value for DN is questionable, and findings that suggest the proximal tubule is an important link in the development of DN. The concept of ‘diabetic tubulopathy’ has emerged from recent studies, and its causative role in DN is supported by clinical and experimental evidence, as well as plausible pathogenetic mechanisms. This review explores the ‘tubulocentric’ view of DN. The recent finding that inhibition of proximal tubule (PT) glucose transport (via SGLT2) is nephro-protective in diabetic patients is discussed in relation to the tubule’s potential role in DN. Studies with a tubulocentric view of DN have stimulated alternative clinical approaches to the early detection of diabetic kidney disease. There are tubular biomarkers considered as direct indicators of injury of the proximal tubule (PT), such as N-acetyl-β-D-glucosaminidase, Neutrophil Gelatinase-Associated Lipocalin and Kidney Injury Molecule-1, and other functional PT biomarkers, such as Urine free Retinol-Binding Protein 4 and Cystatin C, which reflect impaired reabsorption of filtered proteins. The clinical application of these measurements to diabetic patients will be reviewed in the context of the need for better biomarkers for early DN.Keywords
This publication has 82 references indexed in Scilit:
- Urinary Cystatin C and Tubular Proteinuria Predict Progression of Diabetic NephropathyDiabetes Care, 2013
- Endocannabinoids and the renal proximal tubule: An emerging role in diabetic nephropathyThe International Journal of Biochemistry & Cell Biology, 2012
- Can We Target Tubular Damage to Prevent Renal Function Decline in Diabetes?Seminars in Nephrology, 2012
- Increased Tubular Proliferation as an Adaptive Response to Glomerular AlbuminuriaJournal of the American Society of Nephrology, 2012
- Mechanisms of Glomerular Albumin Filtration and Tubular ReabsorptionInternational Journal of Nephrology, 2012
- Biology of Human Sodium Glucose TransportersPhysiological Reviews, 2011
- Early Urinary Markers of Diabetic Kidney Disease: A Nested Case-Control Study From the Diabetes Control and Complications Trial (DCCT)American Journal of Kidney Diseases, 2010
- Microalbuminuria in Type 1 Diabetes Is Associated With Enhanced Excretion of the Endocytic Multiligand Receptors Megalin and CubilinDiabetes Care, 2009
- Impaired Tubular Uptake Explains Albuminuria in Early Diabetic NephropathyJournal of the American Society of Nephrology, 2009
- Histopathology of Diabetic NephropathySeminars in Nephrology, 2007